Home LiteratureArticle Details
PMID: 12781533 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Lancet (London, England) ·Vol. 361 ·No. 9371 ·2003-05-24 ·Pages 1761-6

Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, Riley S, Abu-Raddad LJ, Ho LM, Thach TQ, Chau P, Chan KP, Lam TH, Tse LY, Tsang T, Liu SH, Kong JH, Lau EM, Ferguson NM, Anderson RM

Abstract

Health authorities worldwide, especially in the Asia Pacific region, are seeking effective public-health interventions in the continuing epidemic of severe acute respiratory syndrome (SARS). We assessed the epidemiology of SARS in Hong Kong. We included 1425 cases reported up to April 28, 2003. An integrated database was constructed from several sources containing information on epidemiological, demographic, and clinical variables. We estimated the key epidemiological distributions: infection to onset, onset to admission, admission to death, and admission to discharge. We measured associations between the estimated case fatality rate and patients' age and the time from onset to admission. After the initial phase of exponential growth, the rate of confirmed cases fell to less than 20 per day by April 28. Public-health interventions included encouragement to report to hospital rapidly after the onset of clinical symptoms, contact tracing for confirmed and suspected cases, and quarantining, monitoring, and restricting the travel of contacts. The mean incubation period of the disease is estimated to be 6.4 days (95% CI 5.2-7.7). The mean time from onset of clinical symptoms to admission to hospital varied between 3 and 5 days, with longer times earlier in the epidemic. The estimated case fatality rate was 13.2% (9.8-16.8) for patients younger than 60 years and 43.3% (35.2-52.4) for patients aged 60 years or older assuming a parametric gamma distribution. A non-parametric method yielded estimates of 6.8% (4.0-9.6) and 55.0% (45.3-64.7), respectively. Case clusters have played an important part in the course of the epidemic. Patients' age was strongly associated with outcome. The time between onset of symptoms and admission to hospital did not alter outcome, but shorter intervals will be important to the wider population by restricting the infectious period before patients are placed in quarantine.

MeSH Terms
Adolescent Adult Age Distribution Aged Child Child, Preschool Disease Outbreaks/statistics & numerical data Disease Progression Female Hong Kong/epidemiology Humans Incidence Infant Likelihood Functions Male Middle Aged Quarantine/methods,statistics & numerical data Severe Acute Respiratory Syndrome/diagnosis,epidemiology Survival Rate
Authors & Affiliations
19 authors, click to expand affiliations / ORCID
Donnelly Christl A
Department of Infectious Disease Epidemiology, Imperial College, London, UK. c.donnelly@imperial.ac.uk <c.donnelly@imperial.ac.uk>
Ghani Azra C
Leung Gabriel M
Hedley Anthony J
Fraser Christophe
Riley Steven
Abu-Raddad Laith J
Ho Lai-Ming
Thach Thuan-Quoc
Chau Patsy
Chan King-Pan
Lam Tai-Hing
Tse Lai-Yin
Tsang Thomas
Liu Shao-Haei
Kong James H B
Lau Edith M C
Ferguson Neil M
Anderson Roy M
References (2)
2 references, click to expand
  1. A cluster of cases of severe acute respiratory syndrome in Hong Kong.
    N Engl J Med. 2003 May 15;348(20):1977-85 PMID: 12671062
  2. Coronavirus as a possible cause of severe acute respiratory syndrome.
    Lancet. 2003 Apr 19;361(9366):1319-25 PMID: 12711465
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
2003-05-24
Pages
1761-6
Language
English
Region
England
NLM ID
2985213R
PMCID
PMC7112380
Subset
IM
Grants
Wellcome Trust · United Kingdom
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com